Page last updated: 2024-08-26

11-ketoprogesterone and Prostatic Neoplasms

11-ketoprogesterone has been researched along with Prostatic Neoplasms in 2 studies

*Prostatic Neoplasms: Tumors or cancer of the PROSTATE. [MeSH]

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Scott, EE; Swart, AC; van Rooyen, D; Yadav, R1
Bloem, LM; du Toit, T; Gent, R; Swart, AC1

Other Studies

2 other study(ies) available for 11-ketoprogesterone and Prostatic Neoplasms

ArticleYear
CYP17A1 exhibits 17αhydroxylase/17,20-lyase activity towards 11β-hydroxyprogesterone and 11-ketoprogesterone metabolites in the C11-oxy backdoor pathway.
    The Journal of steroid biochemistry and molecular biology, 2020, Volume: 199

    Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; Androgens; Cell Line, Tumor; Gonadal Steroid Hormones; HEK293 Cells; Humans; Hydroxyprogesterones; Male; Progesterone; Prostatic Neoplasms; Steroid 17-alpha-Hydroxylase; Testosterone

2020
The 11β-hydroxysteroid dehydrogenase isoforms: pivotal catalytic activities yield potent C11-oxy C
    The Journal of steroid biochemistry and molecular biology, 2019, Volume: 189

    Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 1; 11-beta-Hydroxysteroid Dehydrogenase Type 2; Androstenes; Biosynthetic Pathways; Cell Line, Tumor; HEK293 Cells; Humans; Male; Progesterone; Prostatic Neoplasms; Protein Isoforms; Substrate Specificity; Testosterone

2019